Results 251 to 260 of about 106,112 (301)

Tolicizumab: a new option for refractory idiopathic recurrent pericarditis: a case report. [PDF]

Eur Heart J Case Rep
Collini V, Venturelli F, Quinzani F, Sappa R, Imazio M.   +4 more
europepmc   +1 more source

EP4 stimulation promotes cell adhesion and migration via IL-6 signaling in oral squamous cell carcinoma. [PDF]

J Physiol Sci
Fukae W, Ishikawa S, Iida Y, Nagasako A, Endo M, Hayashi C, Nagao K, Oguri S, Fujita T, Yokoyama U, Mitsudo K, Ishikawa Y, Umemura M.   +12 more
europepmc   +1 more source

Tocilizumab prophylaxis for patients with multiple myeloma treated with bispecific antibodies. [PDF]

Blood Adv
Kowalski A, Lykon J, Diamond B, Coffey D, Kaddoura M, Maura F, Hoffman J, Pandey A, Kazandjian D, Landgren O.   +9 more
europepmc   +1 more source

Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-Cell lymphoma [PDF]

, 2017
Bartlett, N. L, et al,, Ghobadi, A.
core   +1 more source

Adoption of new treatment options in non-systemic juvenile idiopathic arthritis (JIA) in clinical practice. [PDF]

Pediatr Rheumatol Online J
Lamers HC, Van Nieuwenhove E, Vastert SJ, Jansen MHA, van Royen-Kerkhof A, Swart JF, de Roock S.   +6 more
europepmc   +1 more source

A certolizumab pegol kezelés rheumatoid arthritisben, irodalmi áttekintés és egészség-gazdaságtani elemzés = Certolizumab pegol in patients with rheumatoid arthritis: systematic review and health economic evaluation [PDF]

, 2009
Brodszky, Valentin, Gulácsi, László, Péntek, Márta, Érsek, Katalin   +3 more
core  

Steroid-sparing strategies for managing immune-related adverse events. [PDF]

J Immunother Cancer
Huang JJ, YousefiAsl M, Singh N, Grivas P, Bhatia S.   +4 more
europepmc   +1 more source

Real-World Tocilizumab Use in Pediatric Inpatients. [PDF]

J Pediatr Pharmacol Ther
Stitt GA, Hall MW, Diliberto MA, Zuppa AF.   +3 more
europepmc   +1 more source

The role of early immunotherapy in rasmussen's encephalitis. [PDF]

Neurol Sci
Ronne EJ, Khoshnood MM, Santoro JD.
europepmc   +1 more source